Encouraging structured personalised diabetes care in general practice: A 6-year follow-up study of process and patient outcomes in newly diagnosed patients

Scandinavian Journal of Primary Health Care

Volumn 21, Issue 2, 2003, Pages 89-95

  Hansen, Lars Jø ^a,c   De Fine Olivarius, Niels ^a   Siersma, Volkert ^a   Beck Nielsen, Henning ^b   Pedersen, Poul A ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Changing physician behaviour; Diabetes mellitus; Family practice; Goal setting; Health services research

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; GLIBENCLAMIDE; GLIPIZIDE; GLYCOSYLATED HEMOGLOBIN; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE; THIAZIDE DIURETIC AGENT; TOLBUTAMIDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GENERAL PRACTICE; HEALTH CARE QUALITY; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MOTIVATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PRACTICE GUIDELINE; QUESTIONNAIRE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AGED; DENMARK; DIABETES MELLITUS; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES RESEARCH; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PROGRAM EVALUATION; RISK FACTORS; SELF CARE;

EID: 0037787820     PISSN: 02813432     EISSN: None     Source Type: Journal    
DOI: 10.1080/802813430310001680     Document Type: Article

References (21)

1. Dunn NR, Bough P. Standards of care of diabetic patients in a typical English community. Br J Gen Pract 1996;46:401-5.
2. Nicolucci A, Scorpiglione N, Belfiglio M, Carinci F, Cavaliere D, el-Shazly M, et al. Patterns of care an Italian diabetic population. Diabet Med 1997;14:158-66.
3. Weiner JP, Parente ST, Garnick DW, Fowles J, Lawthers AG, Palmer RH. Variation in office-based quality. A claims-based profile of care provided to Medicare patients with diabetes. JAMA 1995;273:1503-8.
4. Bouma M, Dekker JH, van Eijk JthM, Schellevis FG, Kriegsman DMW, Heine RJ. Metabolic control and morbidity of type 2 diabetic patients in a general practice network. Fam Pract 1999;16:402-6.
5. Butler C, Peters J, Stott N. Glycated haemoglobin and metabolic control of diabetes mellitus: external versus locally established clinical targets for primary care. BMJ 1995;310:784-8.
6. Hetlevik I, Holmen J, Midthjell K. Treatment of diabetes mellitus - physicians' adherence to clinical guidelines in Norway. Scand J Prim Health Care 1997;15:193-7.
7. Hoskins PL, Fowler PM, Constantino M, Forrest J, Yue DK, Turtle JR. Sharing the care of diabetic patients between hospital and general practitioners: does it work? Diabet Med 1993;10:81-6.
8. Hurwitz B, Goodman C, Yudkin J, Kinmonth AL, Pringle M, Stewart-Evans C, et al. Prompting the clinical care of non-insulin dependent (type II) diabetic patients in an inner city area: one model of community care. BMJ 1993;306:624-30.
9. Anonymous. Integrated care for diabetes: clinical, psychosocial, and economic evaluation. Diabetes Integrated Care Evaluation Team. BMJ 1994;308:1208-12.
10. Renders CM, Valk GD, Griffin S, Wagner EH, Eijk JthM van, Assendelft WJJ. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings (Cochrane Review). In: The Cochrane Library, Issue 2, 2001. Oxford: Update Software, 2001.
11. Olivarius NdeF, Beck-Nielsen H, Andreasen AH, Horder M, Pedersen PA. Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ 2001;323:970-5.
12. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods. Geneva: WHO, 1982.
13. Griffin SJ. Lost to follow-up: the problem of defaulters from diabetes clinics. Diabet Med 1998;15(Suppl 3):14-24.
14. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
15. Anonymous. A desktop guide to type 2 diabetes mellitus. European Diabetes Policy Group 1999. Diabet Med 1999;16:716-30.
16. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2000;23 (Suppl 1):S32-42.
17. Anonymous. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 1993;11:309-17.
18. Sprafka JM, Bender AP, Jagger HG. Prevalence of hypertension and associated risk factors among diabetic individuals. The Three-City Study. Diabetes Care 1988;11:17-22.
19. Anonymous. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998;317:713-20.
20. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian simvastatin survival study (4S). Diabetes Care 1997;20:614-20.
21. Brown SA, Upchurch S, Anding R, Winter M, Ramirez G. Promoting weight loss in type II diabetes. Diabetes Care 1996;19:613-24.